Antibiotic usage and resistance in different regions of the Dutch community

被引:16
作者
Bruinsma, N
Filius, PMG
De Smet, PAGM
Degener, J
Endtz, P
Van den Bogaard, AE
Stobberingh, EE
机构
[1] Univ Hosp Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands
[2] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[3] Sci Inst Dutch Pharmacists, The Hague, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[5] Univ Groningen Hosp, Dept Med Microbiol, Groningen, Netherlands
关键词
D O I
10.1089/107662902760326922
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Regional differences of antibiotic use and antibiotic resistance in the fecal indicator bacteria Escherichia coli and enterococci were determined in different cities in the south, west, and north of The Netherlands. In 1999, differences in antibiotic consumption were observed between the different regions: 11.19, 10.84, and 7.16 DDD (defined daily dosage) per 1,000 inhabitants per day, respectively. No significant regional differences were found in the prevalence of antibiotic resistance for both E. coli and enterococci. However, the differences in antibiotic consumption observed might lead to changes in antibiotic resistance in the near future. Surveillance of antibiotic use and antibiotic resistance is strongly recommended to control the development of antibiotic resistance because it provides epidemiological data to set up and control antibiotic guidelines.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 48 条
[1]  
BAART F, 2001, PHARMACEUTISCH WEEKB, V22, P786
[2]   Surveillance of antimicrobial resistance - what, how and whither? [J].
Bax, R ;
Bywater, R ;
Cornaglia, G ;
Goossens, H ;
Hunter, P ;
Isham, V ;
Jarlier, V ;
Jones, R ;
Phillips, I ;
Sahm, D ;
Senn, S ;
Struelens, M ;
Taylor, D ;
White, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (06) :316-325
[3]   The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage [J].
Bradley, SJ ;
Wilson, ALT ;
Allen, MC ;
Sher, HA ;
Goldstone, AH ;
Scott, GM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :261-266
[4]  
BUCHHOLZ U, 2001, 11 EUR C CLIN MICR I
[5]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[6]   The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens [J].
Cizman, M ;
Pokorn, M ;
Seme, K ;
Orazem, A ;
Paragi, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) :475-477
[7]  
DOMINGUEZ EA, 2000, INFECT CONTROL HO S1, V21, P4
[8]   AN OUTBREAK OF MEASLES AT AN INTERNATIONAL SPORTING EVENT WITH AIRBORNE TRANSMISSION IN A DOMED STADIUM [J].
EHRESMANN, KR ;
HEDBERG, CW ;
GRIMM, MB ;
NORTON, CA ;
MACDONALD, KL ;
OSTERHOLM, MT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :679-683
[9]   Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction [J].
Enne, VI ;
Livermore, DM ;
Stephens, P ;
Hall, LMC .
LANCET, 2001, 357 (9265) :1325-1328
[10]   Mechanisms of macrolide resistance in clinical pneumococcal isolates in France [J].
Fitoussi, F ;
Doit, C ;
Geslin, P ;
Brahimi, N ;
Bingen, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :636-638